China Pharma Holdings (CPHI) Assets Average (2016 - 2025)
Historic Assets Average for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $14.8 million.
- China Pharma Holdings' Assets Average rose 665.24% to $14.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 665.24%. This contributed to the annual value of $15.7 million for FY2024, which is 845.65% down from last year.
- Per China Pharma Holdings' latest filing, its Assets Average stood at $14.8 million for Q3 2025, which was up 665.24% from $14.0 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Assets Average ranged from a high of $21.8 million in Q1 2022 and a low of $13.9 million during Q3 2024
- Its 5-year average for Assets Average is $17.0 million, with a median of $16.5 million in 2023.
- In the last 5 years, China Pharma Holdings' Assets Average skyrocketed by 665.78% in 2022 and then crashed by 1957.43% in 2023.
- Quarter analysis of 5 years shows China Pharma Holdings' Assets Average stood at $20.4 million in 2021, then dropped by 16.76% to $17.0 million in 2022, then fell by 6.37% to $15.9 million in 2023, then decreased by 10.9% to $14.2 million in 2024, then grew by 4.3% to $14.8 million in 2025.
- Its Assets Average stands at $14.8 million for Q3 2025, versus $14.0 million for Q2 2025 and $14.6 million for Q1 2025.